{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:06:21Z","timestamp":1769724381953,"version":"3.49.0"},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    CM313, a novel humanized anti\u2010CD38 monoclonal antibody, has demonstrated therapeutic potential in autoimmune diseases. This Phase 1 trial evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy participants following single ascending doses of CM313. Fifty\u2010one participants received CM313 or placebo by SC injection at doses of 150\u2009mg (1:1), 300\u2009mg (2:1), and 600\u2009mg (2:1), or by IV infusion at 8\u2009mg\/kg (2:1). All completed the trial. Treatment\u2010emergent adverse events occurred in 90.9% of CM313\u2010treated participants and 83.3% of placebo\u2010treated participants, all mild or moderate. No serious adverse events were reported. SC injections of CM313 demonstrated a notably lower incidence of infusion\u2010related reactions (600\u2009mg SC: 20%) than IV infusion (8\u2009mg\/kg IV: 60%). CM313 exhibited nonlinear pharmacokinetics. Following a single SC dose, the median\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    was 2.00\u20133.00\u2009days, mean\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    was 4.75\u201387.40\u2009\u03bcg\/mL, mean AUC\n                    <jats:sub>\n                      0\u2010\n                      <jats:italic>t<\/jats:italic>\n                    <\/jats:sub>\n                    was 20.29\u20131262.50\u2009day*\u03bcg\/mL, mean\n                    <jats:italic>V<\/jats:italic>\n                    <jats:sub>z<\/jats:sub>\n                    \/\n                    <jats:italic>F<\/jats:italic>\n                    was 2.63\u201321.20\u2009L, mean clearance was 0.50\u20137.90\u2009L\/day, and mean half\u2010life was 1.85\u20133.90\u2009days. The bioavailability of the 600\u2009mg SC dose was 66% of the 8\u2009mg\/kg IV dose. CM313 induced rapid and sustained reductions in total IgA, IgE, IgG, and IgM levels by 40%\u201380% from baseline. Both SC and IV formulations demonstrated potent CD38 binding activity and markedly depleted NK cells by \u2265\u200990% within 2\u2009days. CM313 also achieved 80%\u201390% CD38 receptor occupancy on B cells, T cells, and monocytes within 1 week. Overall, single doses of CM313 demonstrated favorable safety, tolerability, PK, and PD in healthy participants.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial Registration:<\/jats:bold>\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                    (NCT06285227)\n                  <\/jats:p>","DOI":"10.1111\/cts.70334","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T15:55:36Z","timestamp":1758210936000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics, Pharmacodynamics, and Immunogenicity of\n                    <scp>CM313<\/scp>\n                    in Healthy Participants: An Open\u2010Label\/Double\u2010Blind, Randomized, Placebo\u2010Controlled Phase 1 Trial"],"prefix":"10.1111","volume":"18","author":[{"given":"Shuyan","family":"Yu","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Research Center, Huashan Hospital Fudan University  Shanghai China"},{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital Fudan University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhen","family":"Wu","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Research Center, Huashan Hospital Fudan University  Shanghai China"},{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital Fudan University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxue","family":"Zhao","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Research Center, Huashan Hospital Fudan University  Shanghai China"},{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital Fudan University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjie","family":"He","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Research Center, Huashan Hospital Fudan University  Shanghai China"},{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital Fudan University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyue","family":"Yan","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Yang","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Song","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoyun","family":"Hou","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bujing","family":"Guo","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Qiu","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Keymed Biosciences (Chengdu) Co., Ltd.  Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xue","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital Fudan University  Shanghai China"},{"name":"Department of Rheumatology and Immunology, Huashan Hospital Fudan University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2966-9149","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Research Center, Huashan Hospital Fudan University  Shanghai China"},{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital Fudan University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201006\u2010740944"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8235624"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167\u20105699(94)90148\u20101"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00035.2007"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.02.001"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen\u20102023\u2010003604"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/bf03347507"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.597959"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103289"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102743"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010077"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400409"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075\u2010018\u20101578\u2010z"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023325"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102024\u2010eular.LBA26"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010023\u201002479\u20101"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1410457"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.Hs9.0000970604.12677.40"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14241"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010019\u20100198\u20104"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506348"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S303279"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271\u2010014\u20100075\u2010y"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70334","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cts.70334","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T10:24:20Z","timestamp":1769682260000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.70334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1111\/cts.70334"],"URL":"https:\/\/doi.org\/10.1111\/cts.70334","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70334"}}